Nurix Therapeutics Inc (NRIX)
14.69
+0.15
(+1.03%)
USD |
NASDAQ |
Mar 28, 16:00
14.41
-0.28
(-1.91%)
Pre-Market: 20:00
Nurix Therapeutics Total Assets (Quarterly): 355.60M for Nov. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
November 30, 2023 | 355.60M |
August 31, 2023 | 308.20M |
May 31, 2023 | 350.62M |
February 28, 2023 | 370.15M |
November 30, 2022 | 416.76M |
August 31, 2022 | 459.34M |
May 31, 2022 | 394.31M |
February 28, 2022 | 437.72M |
Date | Value |
---|---|
November 30, 2021 | 476.77M |
August 31, 2021 | 493.07M |
May 31, 2021 | 517.98M |
February 28, 2021 | 396.66M |
November 30, 2020 | 396.34M |
August 31, 2020 | 411.87M |
May 31, 2020 | 213.28M |
November 30, 2019 | 44.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
44.05M
Minimum
Nov 2019
517.98M
Maximum
May 2021
377.67M
Average
396.50M
Median
Total Assets (Quarterly) Benchmarks
Biogen Inc | 26.84B |
UroGen Pharma Ltd | 178.31M |
Deciphera Pharmaceuticals Inc | 473.57M |
Apellis Pharmaceuticals Inc | 788.73M |
CEL-SCI Corp | 28.71M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 155.10M |
Shareholders Equity (Quarterly) | 200.49M |
Current Ratio | 3.398 |